Exelixis (EXEL) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Exelixis Revenue Highlights

Latest Revenue (Y)

$1.83B

Latest Revenue (Q)

$478.06M

Main Segment (Y)

Product, Gross

Main Geography (Y)

UNITED STATES

Exelixis Revenue by Period

Exelixis Revenue by Year

Date	Revenue	Change
2023-12-29	$1.83B	13.60%
2022-12-30	$1.61B	12.27%
2021-12-31	$1.43B	45.31%
2021-01-01	$987.54M	2.04%
2020-01-03	$967.77M	13.35%
2018-12-28	$853.83M	88.70%
2017-12-29	$452.48M	136.34%
2016-12-30	$191.45M	415.05%
2016-01-01	$37.17M	48.03%
2014-12-31	$25.11M	-19.87%
2013-12-31	$31.34M	-33.96%
2012-12-28	$47.45M	-83.62%
2011-12-30	$289.64M	56.52%
2010-12-31	$185.04M	21.93%
2010-01-01	$151.76M	28.76%
2009-01-02	$117.86M	3.87%
2007-12-28	$113.47M	15.00%
2006-12-29	$98.67M	29.90%
2005-12-31	$75.96M	43.71%
2004-12-31	$52.86M	2.56%
2003-12-31	$51.54M	16.29%
2002-12-31	$44.32M	8.09%
2001-12-31	$41.01M	65.62%
2000-12-31	$24.76M	135.80%
1999-12-31	$10.50M	362.15%
1998-12-31	$2.27M	-

Exelixis generated $1.83B in revenue during NA 2023, up 13.60% compared to the previous quarter, and up 214.35% compared to the same period a year ago.

Exelixis Revenue by Quarter

Date	Revenue	Change
2024-09-27	$478.06M	-24.97%
2024-06-28	$637.18M	49.84%
2024-03-29	$425.23M	-11.35%
2023-12-29	$479.65M	1.64%
2023-09-29	$471.92M	0.44%
2023-06-30	$469.85M	14.94%
2023-03-31	$408.79M	-3.57%
2022-12-30	$423.92M	2.96%
2022-09-30	$411.74M	-1.83%
2022-07-01	$419.43M	17.82%
2022-04-01	$355.98M	-21.09%
2021-12-31	$451.14M	37.37%
2021-10-01	$328.42M	-14.73%
2021-07-02	$385.18M	42.54%
2021-04-02	$270.23M	0.07%
2021-01-01	$270.05M	16.86%
2020-10-02	$231.09M	-10.94%
2020-07-03	$259.48M	14.35%
2020-04-03	$226.91M	-5.57%
2020-01-03	$240.31M	-11.55%
2019-09-27	$271.70M	13.08%
2019-06-28	$240.28M	11.50%
2019-03-29	$215.49M	-5.74%
2018-12-28	$228.60M	1.42%
2018-09-28	$225.40M	21.11%
2018-06-29	$186.11M	-12.36%
2018-03-30	$212.35M	76.85%
2017-12-29	$120.07M	-21.27%
2017-09-29	$152.51M	54.04%
2017-06-30	$99.01M	22.40%
2017-03-31	$80.89M	4.26%
2016-12-30	$77.58M	24.74%
2016-09-30	$62.19M	71.56%
2016-07-01	$36.25M	134.99%
2016-04-01	$15.43M	55.23%
2015-12-31	$9.94M	0.85%
2015-09-30	$9.85M	23.30%
2015-06-30	$7.99M	-14.87%
2015-03-31	$9.39M	27.68%
2014-12-31	$7.35M	16.88%
2014-09-30	$6.29M	-4.13%
2014-06-30	$6.56M	33.78%
2014-03-31	$4.91M	12.84%
2013-12-31	$4.35M	-20.47%
2013-09-30	$5.47M	-53.90%
2013-06-30	$11.86M	22.62%
2013-03-31	$9.67M	23.74%
2012-12-31	$7.81M	-41.31%
2012-09-30	$13.31M	70.40%
2012-06-30	$7.81M	-57.79%
2012-03-31	$18.51M	-80.16%
2011-12-31	$93.31M	-27.26%
2011-09-30	$128.27M	298.83%
2011-06-30	$32.16M	-10.39%
2011-03-31	$35.89M	-11.98%
2010-12-31	$40.78M	-25.15%
2010-09-30	$54.47M	14.45%
2010-06-30	$47.60M	12.79%
2010-03-31	$42.20M	-4.26%
2009-12-31	$44.08M	-19.82%
2009-09-30	$54.98M	100.63%
2009-06-30	$27.40M	8.30%
2009-03-31	$25.30M	-14.44%
2009-01-02	$29.57M	-1.20%
2008-09-26	$29.93M	-1.58%
2008-06-27	$30.41M	8.83%
2008-03-28	$27.94M	-

Exelixis generated $478.06M in revenue during Q3 2024, up -24.97% compared to the previous quarter, and up 101.75% compared to the same period a year ago.

Exelixis Revenue Breakdown

Exelixis Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Jan 21	Jan 20
Product, Sales Discounts And Allowances	$-643.65M	$-549.93M	$-375.66M	$-221.04M	$-197.67M
Collaboration	$201.33M	$209.82M	$357.71M	$245.99M	$207.82M
License	$178.63M	-	-	-	-
Product	$1.63B	$1.40B	$1.08B	$741.55M	$759.95M
Product, Gross	$2.27B	$1.95B	$1.45B	$962.59M	$957.62M
Service	$22.69M	-	-	-	-
Collaboration, Research And Development Service	-	-	-	-	$49.97M
Cabometyx	-	-	-	-	$733.42M
Collaboration, License	-	-	-	-	$161.30M
Collaboration, Other	-	-	-	-	$-3.44M
Cometriq	-	-	-	-	$26.53M

Exelixis's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product, Gross (62.08%), Product (44.50%), Collaboration (5.50%), License (4.88%), Service (0.62%), and Product, Sales Discounts And Allowances (-17.58%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jul 22	Apr 22	Dec 21	Oct 21	Jul 21	Apr 21	Jan 21	Oct 20	Jul 20	Apr 20	Jan 20	Sep 19	Jun 19
Product	$478.06M	$378.52M	$429.34M	$426.50M	$409.65M	$363.40M	$366.48M	$347.04M	$310.30M	$302.68M	$263.12M	$284.25M	$227.21M	$200.35M	$168.59M	$178.73M	$193.88M	$194.93M	$191.77M	$193.68M
Collaboration	$61.48M	$46.70M	$50.32M	$45.42M	$60.20M	$45.39M	$45.26M	$72.38M	$45.68M	$148.46M	$65.31M	$100.93M	$43.02M	$45.38M	$79.94M	-	-	-	-	-
License	$60.24M	$44.68M	$136.27M	$42.37M	$68.03M	$36.39M	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product, Gross	$646.42M	$563.78M	$597.60M	$590.44M	$563.17M	$521.32M	$496.14M	$483.07M	$448.24M	$401.04M	$357.46M	$380.20M	$314.20M	$253.54M	$239.92M	$240.42M	-	-	-	-
Product, Sales Discounts And Allowances	$-168.36M	$-185.26M	-	$-163.94M	$-153.53M	$-157.92M	$-129.66M	$-136.03M	$-137.94M	$-98.36M	$-94.34M	$-95.96M	$-86.99M	-	-	-	-	-	-	-
Service	$1.24M	$2.03M	$19.64M	$3.06M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cometriq	-	-	-	-	-	-	-	-	-	-	-	-	-	$4.05M	$9.03M	$5.12M	$4.66M	$13.82M	-	-
Cabometyx	-	-	-	-	-	-	-	-	-	-	-	-	-	$196.31M	$159.56M	$173.61M	$189.22M	$181.11M	-	-
Sales Discounts And Allowances	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$48.15M	$46.74M
Other Collaboration	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$-1.09M	$-691.00K
Research and Development	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$12.99M	$10.90M

Exelixis's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product, Gross (59.90%), Product (44.30%), Collaboration (5.70%), License (5.58%), Service (0.12%), and Product, Sales Discounts And Allowances (-15.60%).

Exelixis Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Jan 21	Jan 20
Europe	$144.97M	$168.59M	$302.07M	$151.63M	$152.77M
UNITED STATES	$1.65B	$1.41B	$1.09B	$752.89M	$770.24M
JAPAN	$39.49M	$28.73M	$43.50M	$83.02M	$44.76M

Exelixis's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (89.92%), Europe (7.92%), and JAPAN (2.16%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jul 22	Apr 22	Dec 21	Oct 21	Jul 21	Apr 21	Jan 21	Oct 20	Jul 20	Apr 20	Jan 20	Sep 19	Jun 19
Europe	$51.08M	$35.70M	$38.68M	$36.02M	$36.73M	$33.53M	$34.82M	$62.24M	$34.53M	$139.25M	$38.09M	$90.92M	$33.81M	$33.67M	$36.01M	$52.92M	$29.04M	$32.64M	$76.02M	$22.25M
UNITED STATES	$481.46M	$381.94M	$432.66M	$429.61M	$416.04M	$367.44M	$369.48M	$349.62M	$314.06M	$305.81M	$266.44M	$287.19M	$229.96M	$203.51M	$171.55M	$181.23M	$196.60M	$197.29M	$194.48M	$196.35M
JAPAN	$7.00M	$7.59M	$8.31M	$6.29M	$17.07M	$7.81M	$7.44M	$7.57M	$7.39M	$6.08M	$23.89M	$7.07M	$6.47M	$32.87M	$23.53M	$25.33M	$1.28M	$10.39M	$1.20M	$21.68M

Exelixis's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (89.24%), Europe (9.47%), and JAPAN (1.30%).

Exelixis Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
BMRN	BioMarin Pharmaceutical	$2.42B	$733.87B
EXEL	Exelixis	$1.83B	$478.06M
ALNY	Alnylam Pharmaceuticals	$1.83B	$420.15M
SRPT	Sarepta Therapeutics	$1.24B	$362.93M
PTCT	PTC Therapeutics	$937.82M	$135.42M
HALO	Halozyme Therapeutics	$829.25M	$290.08M
TGTX	TG Therapeutics	$233.66M	$83.88M
KRYS	Krystal Biotech	$50.70M	$83.84M
BTAI	BioXcel Therapeutics	$1.38M	$1.10M
XFOR	X4 Pharmaceuticals	-	$560.00K
VKTX	Viking Therapeutics	-	-
PDSB	PDS Bio	-	-
MDGL	Madrigal Pharmaceuticals	-	$62.17M
KOD	Kodiak Sciences	-	-

EXEL Revenue FAQ

What is Exelixis’s yearly revenue?

Exelixis's yearly revenue for 2023 was $1.83B, representing an increase of 13.60% compared to 2022. The company's yearly revenue for 2022 was $1.61B, representing an increase of 12.27% compared to 2021. EXEL's yearly revenue for 2021 was $1.43B, representing an increase of 45.31% compared to 2020.

What is Exelixis’s quarterly revenue?

Exelixis's quarterly revenue for Q3 2024 was $478.06M, a -24.97% decrease from the previous quarter (Q2 2024), and a 1.30% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $637.18M, a 49.84% increase from the previous quarter (Q1 2024), and a 35.61% increase year-over-year (Q2 2023). EXEL's quarterly revenue for Q1 2024 was $425.23M, a -11.35% decrease from the previous quarter (Q4 2023), and a 4.02% increase year-over-year (Q1 2023).

What is Exelixis’s revenue growth rate?

Exelixis's revenue growth rate for the last 3 years (2021-2023) was 27.54%, and for the last 5 years (2019-2023) was 89.12%.

What are Exelixis’s revenue streams?

Exelixis's revenue streams in c 23 are Product, Sales Discounts And Allowances, Collaboration, License, Product, Product, Gross, and Service. Product, Sales Discounts And Allowances generated $-644M in revenue, accounting -17.58% of the company's total revenue, up 17.04% year-over-year. Collaboration generated $201.33M in revenue, accounting 5.50% of the company's total revenue, down -4.05% year-over-year. License generated $178.64M in revenue, accounting 4.88% of the company's total revenue Product generated $1.63B in revenue, accounting 44.50% of the company's total revenue, up 16.25% year-over-year. Product, Gross generated $2.27B in revenue, accounting 62.08% of the company's total revenue, up 16.47% year-over-year. Service generated $22.69M in revenue, accounting 0.62% of the company's total revenue

What is Exelixis’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Exelixis was Product, Gross. This segment made a revenue of $2.27B, representing 62.08% of the company's total revenue.